An Open-Label ProSpective MultiCENTer Study to Evaluate Safety and Tolerability of Dry Powder Inhaled Treprostinil in PH

Part of paid clinical trials in Phoenix, Arizona.

Sponsor
Liquidia Technologies, Inc.
Study ID
NCT06129240
Status
Recruiting
Apply to this trial

Conditions

  • Interstitial Lung Disease
  • Pulmonary Hypertension

Eligibility Criteria

Sex
ALL
Age
18 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • LIQ861 — DRUG
    trepostinil inhalation powder in combination with inhaler

Study Details

Study LTI-401 is an open-label, multicenter study which will evaluate the safety and tolerability of LIQ861 in subjects who have WHO Group 1 \& 3 PH.

Key Dates

Start date
Dec 28, 2023
Status verified
Jun 2026
Primary completion
Jul 31, 2027
Completion
Feb 8, 2028

Study Design

Enrollment
80 participants (estimated)

Arms

  • Arm: Cohort A
    PH-ILD
  • Arm: Cohort B
    PH-ILD

Primary Outcome Measure

Cohort A: Incident of treatment-emergent drug/device-related adverse events and Serious Adverse Events (SAEs) [ Time Frame: Baseline until the end of the study. ]

Locations (23)

FacilityCityStateZIPSite coordinators
Arizona Pulmonary SpecialistsPhoenixArizona85012
Akshay Muraldihar
[email protected]
602-271-0832
The Medical Research Group, Inc.FresnoCalifornia93720
Vijay Balasubramanian
[email protected]
(559) 367-3095
University of California San DiegoLa JollaCalifornia92093-
UCLA WestwoodLos AngelesCalifornia90095-
UC DavisSacrementoCalifornia95817-
UCSFSan FranciscoCalifornia94143-
National Jewish HealthDenverColorado80206
Patty George
[email protected]
303-398-1233
Hartford HospitalHartfordConnecticut06102-
Advent HealthOrlandoFlorida32803
James Tarver
[email protected]
407-303-9984
Tampa General Hospital Center of Research ExcellenceTampaFlorida33606
Ricardo Restrepo
[email protected]
215-964-7399
Vincent Medical GroupIndianapolisIndiana46260
Ashwin Ravichandran
[email protected]
317-338-8042
Norton Pulmonary SpecialistsLouisvilleKentucky40241-
Tufts Medical CenterBostonMassachusetts02111-
University of MichiganAnn ArborMichigan48109-
University of MinnesotaMinneapolisMinnesota55455-
NYU Langone Medical CenterNew YorkNew York10016-
University of RochesterRochesterNew York14627-
University of North Carolina at Chapel HillChapel HillNorth Carolina27514-
University of Cincinnati HealthCincinnatiOhio45219-
Summit HealthBendOregon97701
Jeremy Feldman
[email protected]
541-382-2811
Medical University of South CarolinaCharlestonSouth Carolina29425
Rachana Krishna
[email protected]
843-792-3711
Houston MethodistHoustonTexas77030-
University of UtahSalt Lake CityUtah84112-

Find similar trials in Phoenix, AZ

By research site
Arizona Pulmonary Specialists· Phoenix, AZThe Medical Research Group, Inc.· Fresno, CAUniversity of California San Diego· La Jolla, CAUCLA Westwood· Los Angeles, CAUC Davis· Sacremento, CAUCSF· San Francisco, CA

Related Studies